ÇAĞAN, M. Et Al. 2023. Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome. Human antibodies , vol.31, no.1-2 , 1-8.

ÇAĞAN, M., DÖNMEZ, H. G., DİKMEN, Z. G., & BEKSAÇ, M. S., (2023). Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome. Human antibodies , vol.31, no.1-2, 1-8.

ÇAĞAN, MURAT Et Al. "Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome," Human antibodies , vol.31, no.1-2, 1-8, 2023

ÇAĞAN, MURAT Et Al. "Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome." Human antibodies , vol.31, no.1-2, pp.1-8, 2023

ÇAĞAN, M. Et Al. (2023) . "Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome." Human antibodies , vol.31, no.1-2, pp.1-8.

@article{article, author={MURAT ÇAĞAN Et Al. }, title={Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome}, journal={Human antibodies}, year=2023, pages={1-8} }